# FDA 483 - SCA Pharmaceuticals, Inc. - November 07, 2019

Source: https://www.globalkeysolutions.net/records/483/sca-pharmaceuticals-inc/d9de0613-d136-4442-8e3b-9a488253e118

> FDA 483 for SCA Pharmaceuticals, Inc. on November 07, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: SCA Pharmaceuticals, Inc.
- Inspection Date: 2019-11-07
- Product Type: Drugs
- Office Name: Dallas District Office

## Related Documents

- [483 - 2014-04-01](https://www.globalkeysolutions.net/records/483/sca-pharmaceuticals-inc/bebda7d8-bc7f-4e1e-936d-e4c84617ff8a)
- [483 - 2017-09-29](https://www.globalkeysolutions.net/records/483/sca-pharmaceuticals-inc/5831d7f5-785d-463c-bae7-4147c44b70f4)
- [483 - 2023-05-17](https://www.globalkeysolutions.net/records/483/sca-pharmaceuticals-inc/81934160-17f4-4812-95ec-e80afc9332a6)
- [483 - 2025-10-20](https://www.globalkeysolutions.net/records/483/sca-pharmaceuticals-inc/b241011e-ec18-43b3-ba69-6aae9c51750b)

## Related Officers

- [CO CDER OMQ](https://www.globalkeysolutions.net/people/claire-m-minden/f48982ad-244e-41a8-932a-5d7a2392f0e3)

Company: https://www.globalkeysolutions.net/companies/sca-pharmaceuticals-inc/2ef86fd7-d7d9-4bed-9ad6-24594b9b1f94

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9